iBio, Inc. (IBIO): Price and Financial Metrics

IBIO POWR Grades

• Value is the dimension where IBIO ranks best; there it ranks ahead of 42.41% of US stocks.
• IBIO's strongest trending metric is Sentiment; it's been moving up over the last 106 days.
• IBIO's current lowest rank is in the Quality metric (where it is better than 0.62% of US stocks).

IBIO Stock Summary

• With a market capitalization of $6,471,923, IBIO INC has a greater market value than merely 1.63% of US stocks.
• The volatility of IBIO INC's share price is greater than that of 98.48% US stocks with at least 200 days of trading history.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for IBIO comes in at 74.88% -- higher than that of 97.65% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to IBIO INC are EMKR, SCWX, PEAR, LAW, and DZSI.
• IBIO's SEC filings can be seen here. And to visit IBIO INC's official web site, go to www.ibioinc.com.

IBIO Valuation Summary

• In comparison to the median Healthcare stock, IBIO's price/earnings ratio is 100.44% lower, now standing at -0.1.
• Over the past 160 months, IBIO's price/earnings ratio has gone up 9.4.

Below are key valuation metrics over time for IBIO.

IBIO Growth Metrics

The 3 year cash and equivalents growth rate now stands at 339.39%.
• Its 4 year net income to common stockholders growth rate is now at -203.93%.
• Its 4 year revenue growth rate is now at 151.53%.

IBIO's revenue has moved up $1,650,000 over the prior 67 months.

The table below shows IBIO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	2.172	-42.092	-59.516
2022-06-30	2.383	-37.48	-50.391
2022-03-31	2.813	-33.203	-33.286
2021-12-31	1.635	-34.608	-28.621
2021-09-30	2.172	-32.341	-24.873
2021-06-30	2.371	-30.064	-23.467

IBIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IBIO has a Quality Grade of D, ranking ahead of 5.38% of graded US stocks.
• IBIO's asset turnover comes in at 0.017 -- ranking 375th of 681 Pharmaceutical Products stocks.
• COLL, COCP, and IRWD are the stocks whose asset turnover ratios are most correlated with IBIO.

The table below shows IBIO's key quality metrics over time.